成年人腹部肥胖的血清代谢物概况,以应对每天6个月食用1个梨的反应:一个探索性分析
Nirupa R Matthan1, Ecaterina Duscova1, Gregory Matuszek1
1Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston MA USA.
Journal of the American Heart Association
|March 13, 2026
概括
梨的消费微妙地改变了参与脂质,碳水化合物和氨基酸代谢的血清代谢物. 这些变化与肥胖成年人的内脏脂肪组织和脂质水平存在微弱的关联.
科学领域:
- 营养科学 营养科学
- 代谢学 代谢学 代谢学
- 心血管健康 心血管健康
背景情况:
- 梨的消费与改善饮食质量和心脏代谢风险因素有关.
- 然而,它对血清代谢物概况的影响尚不清楚.
研究的目的:
- 为了研究梨摄入量对血清代谢物概况的影响.
- 检查代谢物变化与心脏代谢风险因素之间的关联.
主要方法:
- 使用非向代谢学来分析习惯性饮食和梨试验 (HAT) 参与者的血清样本.
- 在干预前和后评估了代谢物,心脏代谢风险因素和脂肪组织的变化.
- 采用了多级部分最小平方差分分析和多重回归.
主要成果:
- 梨的摄入导致LDL胆固醇和血压降低,但内脏脂肪组织体积增加.
- 30种主要代谢物和45种与脂质相关的代谢物被确定为干预前后差异的关键驱动因素.
- 在96种脂质代谢物和内脏脂肪组织,甘油三和总胆固醇之间发现了微弱至适度的关联.
结论:
- 梨的消费与血清代谢物微妙的变化有关.
- 这些转变涉及脂质,碳水化合物和氨基酸代谢.
- 对内脏脂肪组织和脂质水平的影响很弱.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
262
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262
Overview of Fatty Acid Metabolism
37.6K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.6K
Metabolic States of the Body: The Postabsorptive State
1.5K
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.5K
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Metabolic States of the Body: The Absorptive State
2.0K
During the absorptive state, which lasts approximately four hours after a meal, the body absorbs nutrients from the gastrointestinal tract. The carbohydrates, proteins, and lipids we consume are broken down into monosaccharides, amino acids, and free fatty acids for absorption. While carbohydrates and proteins are absorbed as-is, lipids are absorbed in their broken-down forms and then re-esterified into triglycerides within enterocytes before being packaged into chylomicrons. These absorbed...
2.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
343
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
343


